News Conference News AHA 2018 Complications Following TAVR Are Going Down, US Data Show Yael L. Maxwell November 20, 2018
News Conference News AHA 2018 Concerning Decline in Antibiotic Prophylaxis for Infective Endocarditis Todd Neale November 19, 2018
News Opinion Conversations in Cardiology Conversations in Cardiology: Can a Patient With Tissue Valves Switch From Warfarin to a NOAC? November 16, 2018
News Conference News VIVA 2018 Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease L.A. McKeown November 15, 2018
News Daily News Mortality Outcomes Similar Whether TAVR Performed in Hybrid OR or Cath Lab Yael L. Maxwell November 14, 2018
News Conference News AHA 2018 Rivaroxaban Lowers Thromboembolic Risk in HF Patients: COMMANDER HF Todd Neale November 11, 2018
News Conference News AHA 2018 Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT Michael O'Riordan November 10, 2018
News Conference News AHA 2018 VITAL: No Benefits to Vitamin D and Omega-3s in Reducing Major CV Events, Cancer Shelley Wood November 10, 2018
News Industry News Intact Vascular Announces Positive One-Year Data from the TOBA II Clinical Trial November 07, 2018
News Features Country Roads: Vulnerable West Virginia Heart Patients Targeted in Outreach Program Michael O'Riordan October 29, 2018
News Daily News Big Fitness Equals Big Survival Benefit, New Study Shows Michael O'Riordan October 22, 2018
News Daily News Isolated SAVR Volumes Slide as TAVR Numbers Mount in the US Yael L. Maxwell October 19, 2018
News Daily News Weekend Discharge Not Linked to More Readmissions After Cardiac Surgery Michael O'Riordan October 12, 2018
News Daily News FDA Approves Rivaroxaban for CV Event Reduction in CAD and PAD Patients Todd Neale October 12, 2018
News Opinion Off Script TCT 2018 Off Script: Phantom Hearts and the Elusive Nature of Angina Kwan S. Lee October 11, 2018
News Conference News TCT 2018 Even With PSP, Bioresorbable Scaffold Falls Short in COMPARE-ABSORB and ABSORB IV Trials Michael O'Riordan September 25, 2018
News Conference News TCT 2018 NEOPRO: Two Next-Gen TAVR Valves Show Promise at 30 Days Yael L. Maxwell September 25, 2018
News Conference News TCT 2018 PCI vs CABG at 10 Years: MAIN-COMPARE and SYNTAXES Shine Light on Long-term Outcomes Michael O'Riordan September 25, 2018
News Conference News TCT 2018 Eluvia Gains FDA Approval Just Days After IMPERIAL Results Released Todd Neale September 24, 2018